S100A9诱导伴鼻息肉的慢性鼻窦炎中人鼻上皮组织重塑
本研究用S100A9处理培养的人鼻上皮细胞,并行RNA测序及通路分析,同时对60例患者组织做免疫组化和多重免疫荧光。结果显示S100A9经IL-17信号通路(含MMP1、SPRR2A)诱导鳞状化生,50%的伴鼻息肉慢性鼻窦炎(CRSwNP)出现鳞状化生且S100A9高表达,S100A9表达与SNOT-22(r=0.294,p=0.022)和Lund-Mackay评分(r=0.348,p=0.006)相关,提示其可作为CRS严重度的生物标志物。
要点
- S100A9经IL-17信号通路(涉及MMP1、SPRR2A)诱导人鼻上皮细胞鳞状化生。
- 50%的CRSwNP患者组织可见鳞状化生伴S100A9明显表达。
- S100A9表达与SNOT-22(r=0.294,p=0.022)和Lund-Mackay评分(r=0.348,p=0.006)相关。
核心结论
- S100A9诱导体外人鼻上皮细胞组织重塑,其在CRSwNP尤其鳞状上皮中表达增高并与疾病严重度相关,提示S100A9可作为CRS严重度的生物标志物。
研究设计与样本
- 培养的人鼻上皮细胞经S100A9处理,行RNA测序、基因本体(GO)、Ingenuity通路分析(IPA)和KEGG分析。
- 对60例患者的组织样本行免疫组化和多重免疫荧光,并回顾其临床信息。
主要发现
- GO富集分析提示S100A9诱导人鼻上皮细胞向鳞状化生方向重塑。
- IPA和KEGG共同显示S100A9影响人鼻上皮细胞与IL-17信号通路相关,包括MMP1和SPRR2A等靶分子。
- 50%的CRSwNP患者观察到鳞状化生伴S100A9明显表达。
- 多重免疫荧光显示上皮下S100A9与中性粒细胞标志物髓过氧化物酶共表达,MMP1和SPRR2A在上皮重塑中强表达。
- S100A9表达与SNOT-22评分(r=0.294,p=0.022)和Lund-Mackay评分(r=0.348,p=0.006)相关。
临床怎么用
- 作者认为S100A9有作为CRS严重度生物标志物的临床潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic inflammation triggers tissue remodeling in human nasal epithelial (HNE) cells. S100A9, a protein secreted by inflammatory cells, exhibits potent proinflammatory activity. However, its effect on HNE cell remodeling, such as squamous metaplasia, remains unclear. Therefore, this study aimed to determine the effects and underlying pathways of S100A9 on HNE cell remodeling and investigate its clinical implications in chronic rhinosinusitis (CRS). METHODS: Cultured HNE cells were treated with S100A9. Bulk RNA sequencing was performed to analyze gene ontology (GO). Ingenuity pathway analysis (IPA) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were also analyzed. Additionally, immunohistochemistry and multiplex immunofluorescence were performed on tissue samples obtained from 60 patients, whose clinical informations were also reviewed. RESULTS: GO enrichment analysis indicated that S100A9 induced tissue remodeling in HNE cells toward squamous metaplasia. IPA and KEGG commonly showed that S100A9 affected HNE cells associated with the IL-17 signaling pathway, including target molecules such as matrix metalloproteinase 1 (MMP1) and small proline-rich protein 2A (SPRR2A). Squamous metaplasia with a marked expression of S100A9 was observed in 50% of CRS with nasal polyps (CRSwNPs). In addition, in multiplex immunofluorescence, the S100A9 in sub-epithelium was co-expressed with myeloperoxidase, a neutrophil marker, and MMP1 and SPRR2A were strongly expressed in epithelial remodeling. Clinically, the expression of S100A9 correlated with sino-nasal outcome test-22 (r = 0.294, p = 0.022) and Lund-Mackay scores (r = 0.348, p = 0.006). CONCLUSION: S100A9 induces tissue remodeling in HNE cells. Its increased expression in CRSwNP, particularly squamous epithelium, correlates with disease severity. This suggests the clinical potential of S100A9 as a biomarker for CRS severity.
引用
- Ahn SH, Oh JT, Kim DH, et al. S100A9 induces tissue remodeling of human nasal epithelium in chronic rhinosinusitis with nasal polyp. Int Forum Allergy Rhinol. 2024. PMID: 39367796. doi:10.1002/alr.23460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。